Veru Inc. is an oncology and urology biopharmaceutical company developing and commercializing novel medicines for the prostate cancer continuum of care and urology specialty pharmaceuticals .
May 15, 2019
Listen to the replay of the 2019 Q2 Investors Conference Call
Listen to other presentations and conference calls
We’re looking forward to presenting at the upcoming 2018 Jefferies Healthcare Conference Presentation. As soon as the conference starts, the link will be available. See you there!